The largest database of trusted experimental protocols

Vereos digital pet ct

Manufactured by Philips
Sourced in United States, Netherlands

The Vereos Digital PET/CT is a medical imaging device developed by Philips. It combines positron emission tomography (PET) and computed tomography (CT) technologies to produce high-quality images for diagnostic and treatment planning purposes. The Vereos Digital PET/CT system is designed to offer advanced imaging capabilities, but a detailed description of its core function is not available while maintaining an unbiased and factual approach.

Automatically generated - may contain errors

Lab products found in correlation

7 protocols using vereos digital pet ct

1

Methionine and FDG PET Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All of the patients fasted for at least 6 h before the MET-PET examination. The patients were intravenously injected with [11C]methionine at a dose of 370 MBq/kg body weight and hydrated with 0.9% sodium chloride. Physical activity was kept to a minimum, with a rest period of 10 min post-injection. At 10 min after injection, PET was performed using a PET/computed tomography system (Vereos Digital PET/CT; Philips, Amsterdam, The Netherlands) CT unit and a PET scanner with 23,040 lutetium-yttrium oxyorthosilicate (LYSO) crystals in 64 rings. After that, the patients were intravenously injected with [18F]deoxyglucose at a dose of 4.4 MBq/kg body weight, and PET was performed the same as above.
A low-amperage CT scan was acquired for the attenuation correction of the PET images (213 mA, 120 kV, and CT slice thickness of 5 mm). The CT dose index for low-dose CT was 10.7 mGy. After non-enhanced CT, a total-body PET examination in the caudocranial direction from the upper thighs to the vertex was performed (2 min per bed). Reconstruction was performed using the 3D reconstruction method of ordered subset expectation maximization with 30 subsets and two iterations.
The images were reviewed by a nuclear physician. The standard uptake values (SUV) of the target lesions were measured.
+ Open protocol
+ Expand
2

Validating 3DeliverS Software with NEMA-2012 Phantom

Check if the same lab product or an alternative is used in the 5 most similar protocols
The software was validated using the commercially available NEMA-2012 PET phantom (NEMA-2012). The NEMA-2012 phantom contains six spheres with a known diameter, making it suitable for validation of segmentations in the 3DeliverS software. CT scans of the phantom were already available and were acquired with the Philips Vereos Digital PET/CT, Philips Eindhoven, the Netherlands. The in-plane resolution of the scan was 1.17 mm × 1.17 mm with a slice thickness of 0.67 mm. All spheres were segmented by two independent observers (AB and TO). Segmentation was performed by manually delineating at least the smallest and largest axial contours, using a B-spline contour algorithm. Interpolation was used to calculate all in-between contours. Subsequently, the interpolated contours were manually checked to be located on the inside edges of the spheres. Contours which were not located on the inside edges were manually corrected by the observer, followed by recalculation of the interpolation. This process was repeated until the observer was satisfied with the segmentation result. After segmentation, the contours were converted into a 3D model. The largest axial diameter and 3D volume were then extracted from 3DeliverS, and compared with the specifications according to the manufacturer.
+ Open protocol
+ Expand
3

PET Imaging of Cerebral Tau Tangles

Check if the same lab product or an alternative is used in the 5 most similar protocols
[18F]MK-6240 (Cerveau Technologies, Knoxville TN) is an investigational drug studied as a second-generation cerebral tau tangles imaging agent.
Ninety minutes after intravenous administration of [18F]MK-6240 (target activity 185 ± 5 MBq) a 30-min dynamic list-mode acquisition was performed on a Philips Vereos digital PET-CT (Philips Healthcare, Amsterdam Netherlands). Images were reconstructed using manufacturer’s reconstruction algorithm which includes attenuation, scatter, and decay corrections, and time-of-flight information. Point spread function (PSF) and 1 mm re-slicing was also computed using the manufacturer’s algorithm to obtain a better resolution recovery [16 ].
+ Open protocol
+ Expand
4

Whole-Body PET/CT Protocol for Attenuation Correction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following low-dose CT scans for attenuation correction, whole-body PET scans were acquired from head to mid-thigh with a scan duration of 5 min per bed position, resulting in a total scan duration of approximately 60 min. PET/CT scans were performed either on a Gemini TOF-64 PET/CT scanner or a Vereos digital PET/CT (both from Philips Medical Systems, Best, The Netherlands).
+ Open protocol
+ Expand
5

PSMA-PET/CT Imaging with [18F]DCFPyL and [68Ga]Ga-PSMA-11

Check if the same lab product or an alternative is used in the 5 most similar protocols
For AUMC patients, PSMA-PET/CT imaging was performed with [18F]DCFPyL, a second-generation fluorinated PSMA radiotracer. The scanner used was a Philips Ingenuity (Philips®, Amsterdam, The Netherlands/MA, USA) PET/CT system. [18F]DCFPyL was synthesized at the AUMC on-site cyclotron facility according to Good Manufacturing Practices and was supplied to the NCI for imaging purposes. At the NCI, PSMA-PET/CT imaging was performed with both [68Ga]Ga-PSMA-11 and [18F]DCFPyL tracers using a Philips Gemini TF-II or Vereos Digital PET/CT (Philips®, Amsterdam, The Netherlands/MA, USA). [68Ga]Ga-PSMA-11 was radiolabelled in-house using a fully automated system (Scintomics GmbH, Gräfelfing, Germany). At the NCI, PSMA PET/CT scans were performed 60 min post-injection (p.i.) of both 68Ga-PSMA-11 and [18F]DCFPyL PET/CT, while [18F]DCFPyL PET/CT scans at the AUMC were performed 120 min p.i. [19 (link)]. All PET images were combined with either a low-dose CT (120–140 kV, 40–80 mAs) or a diagnostic CT scan (130 kV, 110 mAs) for anatomical correlation and attenuation correction. All PET images were taken according to the EARL standards and were corrected for scatter, decay and random coincidences [20 (link)].
+ Open protocol
+ Expand
6

PSMA-PET/CT Imaging Protocols for Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the VUmc patients, PSMA‐PET/CT imaging was performed with 18F‐DCFPyL (PSMA), a second‐generation fluorinated PSMA radiotracer. The scanner used was a Philips Ingenuity (Philips®, the Netherlands/USA) PET/CT system. 18F‐DCFPyL (PSMA) was synthesised at the on‐site cyclotron facility according to Good Manufacturing Practices and was also provided to the NCI for imaging purposes. At the NCI, PSMA‐PET/CT imaging was performed with both 68Ga‐PSMA‐11 and 18F‐PSMA tracers, using a Philips Gemini TF‐II or Vereos Digital PET/CT (Philips®, the Netherlands/USA). The 68Ga‐PSMA‐11 was radiolabelled in‐house using a fully automated system (Scintomics GmbH, Germany). All PET‐images were combined with either a low‐dose CT scan (120–140 kV, 40–80 mA) or a diagnostic CT scan (130 kV, 110 mA), for attenuation correction and anatomical localisation. All PET images were corrected for scatter, decay, and random coincidences and were conducted according to EANM Research Ltd. (EARL) standards [20 ].
+ Open protocol
+ Expand
7

Radiolabeled Tau Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
[18F]-MK-6240 (Cerveau Technologies, Knoxville TN) is an investigational drug studied as second-generation cerebral tau tangles imaging agent. Radiosynthesis was performed at KULeuven (Prof. Van Laere) and shipped to our clinic in less than an hour. Ninety minutes after intravenous administration of [18F]-MK-6240 (target activity 185±5 MBq) a 30-min dynamic acquisition (6x5-min frames) was performed on a Philips Vereos digital PET-CT (Philips Healthcare). Images were reconstructed using manufacturer’s standard reconstruction algorithm (including attenuation, scatter, decay correction, and time-of-flight information). We used averaged-6x5 min standardized uptake value ratios (SUVr) measures with partial volume correction using a Point Spread Function (PSF) reconstruction with a FHWM of 2–6 mm and the cerebral white matter as reference region.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!